AstraZeneca starts trial of COVID-19 antibody treatment
AstraZeneca said today that it had begun testing an antibody-based treatment for the prevention and treatment of Covid-19, with the first participants dosed, adding to recent signs of progress on possible medical solutions to the disease.
Business
• 25 Aug 20
